Allocca Biotechnology, LLC

Allocca Biotechnology is a leader of
Advanced Scientific Technology in Healthcare






Neurochemical Reprogramming
for Migraine, Depression, and other Neurotransmitter Problems

Imagine Feeling Better Every Day!
  • Prevent Migraine, Depression, and Other Neurotransmitter Problems
  • Improve Energy, Endurance, and Performance
  • Reduce Pain
  • Reduce Stress
  • Increase Cognitive Function
  • More...
Are you tired of suffering from migraines, depression, and other neurotransmitter problems? Do you struggle with mental focus, cognitive function, or sleep? Look no further than Neurochemical Reprogramming! Neurochemical Reprogramming is designed to upgrade your mind and body, providing you with the tools you need to achieve a healthier, more balanced life.

The loss of neurotransmitters cause problems such as, Migraine Headaches, Depression, Insomnia, Anger, Violence, and Bipolar Syndrome, Decreased Sexuality, Increased Appetite for Carbohydrates, Irritable Bowel Syndrome, Tinnitus, Fibromyalgia, Premenstrual Syndrome (PMS), and Seasonal Affective Disorder (SAD).

Our clinically proven protocol (see Clinical Study, Migraine Testimonials, etc. below), developed by Dr. Allocca, aims to reduce or eliminate substances that cause a loss of neurotransmitters while increasing the intake of substances needed to make neurotransmitters. By doing so, we can help prevent the onset of migraines, depression, and other neurotransmitter problems while improving mental focus and cognitive function. You'll even get better sleep!

Don't rely on pharmaceuticals or other treatments that only mask the symptoms. With neurochemical reprogramming, you can address the root cause of your neurochemical imbalances and experience long-lasting relief. Plus, our protocol includes reducing emotional stress, which can have a positive impact on your overall well-being.

Imagine feeling better every day! Take the first step towards a happier, healthier you and try neurochemical reprogramming today.

You will be guided through the process, ensuring that you get the support and guidance you need to achieve your goals. We use cutting-edge technology and techniques of assessment, nutritional intervention, and our brain synchronization technology called BrainicityTM as developed by medical research scientist Dr. John A. Allocca.






Neurochemical Reprogramming is Part of the Health, Technology, and the Expanding Human Consciousness Program



Clinical Study

A preliminary efficacy study was performed at Eastern Virginia Medical School in 2002 to explore this protocol in the clinical subjects using it. The Migraine / Depression Protocol uses a tyramine-free diet to reduce the diminishment of neurotransmitters and to reduce the vasomotor response of tyramine in the blood stream. The Migraine / Depression Protocol also uses the administration of neurotransmitter precursors to facilitate the adequate synthesis of neurotransmitters in the brain.

Erin E Icenbice and Patricia Shull in a study of "Effects of Neurobiology Formula 12397 on the Headaches of Chronic Migraineurs" in June of 2002 at the Eastern Virginia Medical School, Norfolk, VA found: "Of the participating subjects, 93% were female and 60% older than 45 years of age. Most subjects (60%) were diagnosed with migraines before the age of 18. All participants claimed to experience at least one associated symptom during migraine attacks. Photophobia was reported by all participants, more than 70% of subjects reported suffering from phonophobia and nausea, and greater than 50% noted vomiting with their headaches. More than half of subjects had taken Neurobiology Formula for at least a year while the other half had taken the formula longer. No participants had taken the formula more than 3 years. Compliance with taking the formula was as follows: 26.7% never missed a dose, 46.7% rarely missed a dose, and 26.7% occasionally missed a dose. The dependent variables collectively showed positive results. Participants were asked to state the number of days in a three-month period that problems in question were encountered due to their migraines. Before taking Neurobiology Formula, over 30% of participants missed more than 10 days of work/school or social events. Over 40% missed household work more than 10 days. Impaired productivity on the job was encountered more than 10 days by over half of those surveyed. More than 70% stated they experienced greater than 10 headaches over this time period with an average severity of 8.7 on a scale of 1 to 10. Results concerning the time after subjects had started taking the formula were much different. Approximately 60% of those surveyed reported missing only 0-1 days of work/school, household work and social events over three months, while less than 10% reported missing more than 10 days. More than 40% of subjects experienced only 0-1 days of reduced productivity in the time surveyed. Additionally, subjects experienced fewer headaches with a majority (>50%) having less than 4 headaches over three average of 4.3 on a scale of to 10.""



Migraine Testimonials



Katherine from Virginia writes, Since the age of six, I have lived a life consumed by migraine headaches. I developed migraines in the first grade. Most of the adults in my life doubted the reality of the pain, often saying, "kids don't get headaches." It was not until years later that doctors would prescribe any preventative medication. Later in my adult life, my mother described me as a glassy-eyed child that she felt as though she could do nothing to help. Throughout my adolescence and young adulthood, I was given a variety of seizure drugs, antidepressants and blood pressure medications to prevent these painful episodes. At times, I was having migraines five to six days per week. I became a very meticulous and organized individual because I never knew when the next headache would occur.

I was lucky enough to have periods of time when the medications greatly decreased my migraines; however, this was usually short-lived, and I always used a steady stream of strong and dangerous pain relief medications. I experienced very serious side effects which resulted in several hospitalizations. I felt as though I was destined to have a life that was daily determined by my level of pain. I began to accept this as my fate in life and functioned as well as I possibly could. As I grew older and married, my husband and I began to talk about having children. When I consulted my doctors, most of them were very negative and discouraged my ever becoming pregnant. I was told that not preventative medications were safe during pregnancy, and I was either going to have to risk hurting my unborn child or endure the pain. After conducting my own research, I was left with no more encouraging answers than the ones given by my doctors.

I was beginning to believe that I would have to make this very difficult and painful decision, when I was given information about the Neurobiology program. I had been praying for a solution to my problem and I truly believe that this program was an answer to my prayers. I called and consulted with such caring and helpful people. They helped me to begin the program within one week of my call. I had no idea what joy and freedom were to come from this decision.

I have been on this program for three months. Not only have my migraines been alleviated, but I am now pregnant and continue to be headache free. My OB/GYN has agreed that the Neurobiology vitamins are safe to take during pregnancy and I have had no difficulties thus far.

I am now living a life that is not dictated by pain or the fear of it. I am free to make plans without the worry that I may have to cancel them because of a migraine. This answered prayer has changed my life forever. I would recommend Neurobiology to any chronic migraine sufferer, even the ones like me who thought they had tried everything. I feel like a new person, and I would love to share this with as many people as possible.


Birth Announcement: Hannah was born on 20 October, 2001, 9:07 a.m., 6 lbs. 7.5 oz, 20.75 inches.

Ron from California writes, Dr. Allocca, I am a member of HSI and read their article about your Serotonin product. While I don't have any migraine problems, I've had a lot of other problems relating to depression and anxiety and panic.

Just let me say THANK YOU VERY MUCH for this product. I received it on Thursday of last week and took my first dose of 3 capsules on Friday. I have never felt so good in my entire life. If you should want any further information as to my life experiences that led me to try your product, I will be happy to elaborate. But just let me say that I have had several very traumatic experiences in my life that I have gotten the necessary treatment for. And as far as those things are concerned, I feel that I have dealt with them. However, I have continued to have a sort of anxiety running sort of in the background if you will. Because of this, I have suffered from pains in my stomach, pains in my chest, obsessive thoughts etc.

From the first day that I took Serotonin, these symptoms have all disappeared. In their place is a wonderful feeling of positivity, confidence, just an overall wonderful outlook. I am much more relaxed, and in checking my blood pressure, there seems to be an improvement there too.

I don't get placebo effects from the things I've tried, and I have tried many. Most all did little or nothing. Particularly the prescription anti-depressants.

Again thank you for giving me back my life, I feel REALLY GREAT!




Migraine Patent

Migraine Patent awarded to John A. Allocca


Health Sciences Institute Newsletter

"Beat depression, migraines - and everything in between - with this single serotonin-boosting breakthrough.

If you suffered from migraines, chances are good that your doctor's orders have never reached beyond the limits of simple pain management. And, if you suffer from chronic depression, the outlook for a future of safe and effective solutions have become even bleaker, But it's simply not true. And, if nothing else, SeratoninTM's lengthy track record is proof of that."

Health Sciences Institute Newsletter, October 2007, Vol. 12, No. 4.